Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Start Date
8/1/2026
Completion Date
4/1/2041
Summary
This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.
Detailed Description
Prospective, global, pre-market, interventional, multi-center, randomized controlled pivotal trial to evaluate the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System compared to Edwards EVOQUE TTVR System in symptomatic patients with severe or greater tricuspid regurgitation.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System
Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System
Conditions
Locations
Abrazo Arizona Heart Hospital
Phoenix, Arizona 85016
United States
Los Robles Hospital & Medical Center
Thousand Oaks, California 91360
United States
Abbott Northwestern Hospital
Minneapolis, Minnesota 55407
United States
The Christ Hospital
Cincinnati, Ohio 45219
United States